Pharmacokinetics of Ranitidine in Critically Ill Infants
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Developmental Pharmacology and Therapeutics
- Vol. 12 (1) , 7-12
- https://doi.org/10.1159/000480976
Abstract
The pharmacokinetic parameters of ranitidine were studied following administration of a single intravenous dose in 9 critically ill infants. Ranitidine disposition was best described by a biphasic elimination curve. For 8 patients, the mean values for T 1/2, apparent volume of distribution, and total body clearance were 2.09 h, 1.61 l/kg, and 13.93 ml/min/kg, respectively. Based on simulated steady-state concentration profiles, a dose of 0.7 mg/kg administered intravenously every 6 h should maintain serum levels above 40 ng/ml for 4.7 h of the dosing interval with a wide degree of variability.Keywords
This publication has 7 references indexed in Scilit:
- Rapid analysis of ranitidine in biological fluids and determination of its erythrocyte partitioningJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer diseaseThe Journal of Pediatrics, 1985
- Pharmacokinetics and pharmacodynamics of cimetidine and metabolites in critically ill childrenThe Journal of Pediatrics, 1985
- Ranitidine kinetics and dynamics: I. Oral dose studiesClinical Pharmacology & Therapeutics, 1981
- Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.Gut, 1981
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978